@justagrownwoman's peptide therapy claims need context

What did @justagrownwoman actually say?

She described KPV as acting like "firefighters" that go in and "hose stuff down" during inflammatory flares, specifically naming eczema, psoriasis, chronic inflammation, Crohn's disease, and colitis as target conditions. Her core claim is that KPV calms immune activity "without suppressing it," and she positioned it as a supportive companion to BPC-157, SS-31, and NAD+.

To be fair, the firefighter analogy is actually a reasonable lay explanation for how anti-inflammatory peptides work mechanistically. She didn't claim KPV cures anything, and she didn't throw out dosing numbers or tell anyone to self-inject. That's a lower bar than most peptide content on TikTok clears. But some of what she said goes further than the current evidence supports, particularly the specific disease claims and the "without suppressing it" line.

Does the science back this up?

Partially, yes. KPV is a tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH). There is legitimate preclinical research showing it has anti-inflammatory properties, primarily through interaction with melanocortin receptors, particularly MC1R. That mechanism is real and reasonably well-characterized in cell and animal studies.

Dalmasso et al. (2008, Journal of Leukocyte Biology) showed that KPV reduced colitis severity in mouse models by inhibiting NF-kB signaling, which is a core inflammatory pathway. Kannengiesser et al. (2008, Peptides) added supporting evidence in gut inflammation models. For eczema and psoriasis, there is less direct KPV research, but alpha-MSH pathway work by Bohm et al. (2005, Experimental Dermatology) provides some biological rationale. The problem is that none of this has been tested in randomized controlled human trials. The jump from mouse colitis to "used for Crohn's" in a TikTok is a significant leap that deserves a flag.

What did they get wrong (or right)?

The "without suppressing it" claim is where she gets into trouble. This is a nuanced area. KPV does appear to modulate rather than broadly suppress immune activity, and that's the theoretical selling point. But "modulating" and "not suppressing" are not the same thing, and in some immune contexts, the difference matters. The evidence for selective modulation without any suppressive downstream effects is not clean enough to state this as a simple fact to 38,000 viewers.

The disease list she rattles off, specifically Crohn's and colitis, leans on animal model data as if it were established clinical evidence. That's misleading, not because the mechanism is implausible, but because human clinical data for KPV in those conditions does not exist in any published form as of this writing. Framing preclinical findings as established uses for a condition is a pattern that does real harm in the peptide space. She also mentions "Clitis," which appears to mean ulcerative colitis, worth noting since mispronouncing a condition while discussing its treatment doesn't inspire confidence.

What should you actually know?

KPV is a legitimate research peptide with a plausible mechanism and early-stage preclinical evidence. It is not a proven treatment for any human disease. The anti-inflammatory mechanism involving melanocortin receptor signaling has enough scientific basis that it's worth watching in clinical research, but it's a far cry from something you should be self-administering based on a TikTok.

The stack she mentions, pairing KPV with BPC-157, SS-31, and NAD+, is not validated in any combination study. Combining compounds with overlapping immune-modulating properties without clinical oversight is not inherently safe just because each individual compound sounds benign. If you're dealing with Crohn's disease or ulcerative colitis, those are serious, manageable conditions with actual FDA-approved treatment pathways. Using an unregulated peptide as a primary or adjunct therapy without a physician's supervision is a meaningful health risk, regardless of how good the firefighter metaphor sounds.